Patents by Inventor John O'Mahony

John O'Mahony has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9682235
    Abstract: A system and method are presented that electrically stimulates the phrenic nerve whereby said stimulation results in muscle activation of the diaphragm as observed by a measurement of work or power of breathing associated with the inspiratory portion of a stimulated breath.
    Type: Grant
    Filed: December 14, 2016
    Date of Patent: June 20, 2017
    Assignee: Stimdia Medical, Inc.
    Inventors: John O'Mahony, Patrick J. Wethington
  • Publication number: 20170165480
    Abstract: A system and method are presented that electrically stimulates the phrenic nerve whereby said stimulation results in muscle activation of the diaphragm as observed by a measurement of work or power of breathing associated with the inspiratory portion of a stimulated breath.
    Type: Application
    Filed: December 14, 2016
    Publication date: June 15, 2017
    Applicant: Stimdia Medical, Inc.
    Inventors: John O'Mahony, Patrick J. Wethington
  • Publication number: 20170147166
    Abstract: Extracorporeal blood treatment systems and methods to display graphical user interfaces displaying a plurality of fluids areas, each including a flow rate, and displaying adjustment notifications proximate one or more fluid areas. For example, when a user adjusts a flow rate to a limit, one or more notifications may be displayed proximate other flow rates that may be adjusted to modify the limit.
    Type: Application
    Filed: March 26, 2015
    Publication date: May 25, 2017
    Inventors: Jonas Schaefer, John O'Mahony, Thomas Lendway
  • Patent number: 9440018
    Abstract: A method for filtering blood including: withdrawing blood from an adult patient; performing ultrafiltration by filtering the withdrawn blood in a filter having an active filter membrane surface of no greater than 0.2 meters squared (m2) to remove ultrafiltrate from the blood, wherein the filter membrane blocks the passage of blood molecules having a molecular weight of at least 60,000 Daltons, wherein an amount of the removed ultrafiltrate is an effective therapeutic amount for treating a fluid overload condition of the patient; infusing the ultrafiltrated blood into the adult patient, and pumping the ultrafiltrate from the filter a rate no greater than one liter per hour.
    Type: Grant
    Filed: December 9, 2013
    Date of Patent: September 13, 2016
    Assignee: Gambro Lundia AB
    Inventors: Howard Levin, Mark Gelfand, John O'Mahony, Hans-Dietrich Polaschegg
  • Publication number: 20160038665
    Abstract: Extracorporeal blood treatment systems and methods to display status information for one or more fluids used in extracorporeal blood treatments. For example, a graphical user interface may include a fluids region depicting one or more fluid areas. Each fluid area may include pump and reservoir elements that depict flow rate information, reservoir volume information, and/or a notification related thereto.
    Type: Application
    Filed: March 13, 2014
    Publication date: February 11, 2016
    Inventors: Jonas Schaefer, John O'Mahony, Tom Lendway, Jonathan Lucas, Steve Bernard
  • Publication number: 20160022893
    Abstract: Extracorporeal blood treatment apparatus with reservoir status lights and methods of monitoring reservoir status using the same are described. The extracorporeal blood treatment apparatus include a plurality of reservoir scales (30), each of which is configured to weigh a reservoir (32) used in connection with the extracorporeal blood treatment apparatus. A plurality of reservoir status lights (40) are provided, with one or more of the reservoir status lights (40) associated with one of the reservoir scales (30). The one or more reservoir status lights (40) associated with one of the reservoir scales (30) emit light from a location that is closer to their associated reservoir scale than to any other reservoir scale of the extracorporeal blood treatment apparatus.
    Type: Application
    Filed: March 14, 2014
    Publication date: January 28, 2016
    Inventor: John O'Mahony
  • Publication number: 20150374902
    Abstract: A system, method or apparatus to detect abnormalities in delivery of a fluid may include an infusion apparatus that is controllable to cause one or more perturbations in a fluid flow (e.g., each of the one or more perturbations in the fluid flow may result in a measurable perturbed force response). A force signal representative of the perturbed force response may be used to determine an integrated perturbed force response value (e.g., using integration of the force signal over a perturbation time period; the integrated perturbed force response value being representative of an additional force caused by the at least one perturbation over an equilibrium force). A ratio between the integrated perturbed force response value and a normalizing value (e.g., based at least on a maximum perturbation force of the perturbed force response) may be used to determine if fluid flow is occluded.
    Type: Application
    Filed: December 19, 2013
    Publication date: December 31, 2015
    Inventors: Joshua Chambers, John O'Mahony
  • Publication number: 20150355789
    Abstract: Extracorporeal blood treatment systems and methods to use and modify/create treatment profiles for extracorporeal blood treatments. For example, treatment profiles may include one or more preset, or predefined, settings or values for an extracorporeal blood treatment such as, e.g., therapy type, therapy set (e.g., tubing set, filter set, etc.), anticoagulation type, and one or more flow rates, etc.
    Type: Application
    Filed: December 17, 2013
    Publication date: December 10, 2015
    Inventors: John O'MAHONY, Andrew WENGER
  • Publication number: 20150352294
    Abstract: Syringe pump apparatus and methods for detecting proper or improper engagement of a syringe pump drive system with a syringe in the syringe pump are disclosed. The apparatus and methods can determine proper or improper engagement between a drive system and the plunger of a syringe in a syringe pump by detecting the force required to move a plunger clip in reverse while restricting flow into the syringe. The apparatus and methods may also be used to determine that a syringe in the syringe pump apparatus is properly connected to a delivery line.
    Type: Application
    Filed: December 27, 2013
    Publication date: December 10, 2015
    Inventors: John O'Mahony, Joshua Chambers
  • Publication number: 20150355790
    Abstract: Extracorporeal blood treatment systems and methods to display and select various historical data for extracorporeal blood treatments. Historical data related to extracorporeal blood treatments may be displayed on a two-dimensional graph and in a list view that may be switched there between. Further, historical data may include various datasets (e.g., fluid datasets, patient fluid removal datasets, anticoagulation datasets, etc.) and event information that may be displayed simultaneously.
    Type: Application
    Filed: December 17, 2013
    Publication date: December 10, 2015
    Inventors: John O'Mahony, Jonas Schaefer, Andrew Wenger
  • Publication number: 20150335809
    Abstract: Extracorporeal blood treatment systems and methods to detect the connection of one or more components (e.g., of an extracorporeal blood set) thereto (e.g., to one or more pressure transducers contained in the system housing) by, for example, controlling an air pump apparatus to provide air to a connection port at which the component is to be connected and monitoring pressure resulting therefrom to detect whether the component is operatively connected (e.g., based on a detected change in the monitored pressure due to the increased resistance, based on a monitored rate of decay of pressure of injected air, etc.).
    Type: Application
    Filed: December 16, 2013
    Publication date: November 26, 2015
    Inventors: Rickie L. Stuva, Steve Fyten, John O'Mahony
  • Publication number: 20150314058
    Abstract: Pressure measurement system (e.g., for an extracorporeal treatment system), method and pressure pod apparatus including a position sensor for use in repositioning a diaphragm that separates a liquid side cavity from a transducer side cavity (e.g., operatively connected to a pressure transducer); the liquid side cavity being in fluid communication with an inlet and an outlet.
    Type: Application
    Filed: December 13, 2013
    Publication date: November 5, 2015
    Inventor: John O'Mahony
  • Publication number: 20150306299
    Abstract: Methods and extracorporeal blood treatment systems reposition a diaphragm of a pressure measurement apparatus (e.g., a pressure pod apparatus of an extracorporeal blood set) by, for example, controlling an air pump apparatus to move the diaphragm toward a target measuring position based on a calculated target air volume (e.g., wherein the calculated target air volume is representative of the air volume necessary to move the diaphragm to the target measuring position based at least on a monitored air pressure). For example, after the diaphragm is bottomed out or topped out, as air is added to or removed from the transducer side cavity of a pressure pod apparatus, the target air volume may be iteratively calculated until it is determined that the diaphragm is repositioned in the target measuring position.
    Type: Application
    Filed: December 16, 2013
    Publication date: October 29, 2015
    Inventors: Rickie Stuva, John O'Mahony
  • Patent number: 9089653
    Abstract: An extracorporeal blood processing method using a blood circuit comprising a pair of blood passages attached to opposite flow ends of a blood treatment device and said blood circuit is mounted on a blood pump console, the method includes: withdrawing blood from a vascular system of a human patient and drawing the blood into the blood circuit; pumping the withdrawn blood through one of the pair of blood passages using a first blood pump of the console and into the blood treatment device; pumping the treated blood from the treatment device through the other of the pair of blood passages using a second blood pump of the console; infusing the treated blood from the other blood passage and into the vascular system of the patient, and periodically reversing a flow direction of blood through the pair of blood passages and blood treatment device.
    Type: Grant
    Filed: May 29, 2013
    Date of Patent: July 28, 2015
    Assignee: Gambro UF Solutions, Inc.
    Inventor: John O'Mahony
  • Publication number: 20140231350
    Abstract: A method for filtering blood including: withdrawing blood from an adult patient; performing ultrafiltration by filtering the withdrawn blood in a filter having an active filter membrane surface of no greater than 0.2 meters squared (m2) to remove ultrafiltrate from the blood, wherein the filter membrane blocks the passage of blood molecules having a molecular weight of at least 60,000 Daltons, wherein an amount of the removed ultrafiltrate is an effective therapeutic amount for treating a fluid overload condition of the patient; infusing the ultrafiltrated blood into the adult patient, and pumping the ultrafiltrate from the filter a rate no greater than one liter per hour.
    Type: Application
    Filed: December 9, 2013
    Publication date: August 21, 2014
    Applicant: Gambro UF Solutions, Inc.
    Inventors: Howard Levin, Mark Gelfand, John O'Mahony, Hans-Dietrich Polaschegg
  • Patent number: 8702638
    Abstract: A method and apparatus for controlling blood withdrawal and infusion flow rate with the use of a pressure controller. The pressure controller uses pressure targets based upon occlusion limits that are calculated as a function of flow. The controller has the ability to switch from controlling withdrawal pressure to controlling infusion pressure based upon the detection of an occlusion. The controller distinguishes between partial and total occlusions of the withdrawal vein providing blood access. Depending on the nature of occlusion, the controller limits or temporarily reverses blood flow and, thus, prevents withdrawal vessel collapse or reverses blood flow to quickly infuse blood into the vessel without participation from operator.
    Type: Grant
    Filed: August 24, 2012
    Date of Patent: April 22, 2014
    Assignee: Gambro UF Solutions, Inc.
    Inventors: John O'Mahony, Mark Gelfand, Edward Rychlick
  • Patent number: 8603021
    Abstract: An ultrafiltration filter for an extracorporeal blood circuit having an input for blood withdrawn from a human patient and a blood output for filtered blood to be infused into the patient including: a filter body having a length of at least 20 centimeters (cm) and an interior diameter of no greater than 1.5 cm; an input at a first end of the body to receive the withdrawn blood; an output at a second end of the body to discharge the filtered blood; a filter membrane in the body defining a blood passage through the body, wherein the membrane has an active filter membrane surface area of no greater than 0.2 meters squared (m2) and the filter membrane blocks passage of blood molecules having a molecular weight cut of greater than 60,000 Daltons and a volume of the blood passage in the filter being less than two percent of a cardiac output of the patient, and an ultrafiltrate output to the body and open to a side of the filter surface area opposite to the blood passage.
    Type: Grant
    Filed: May 2, 2011
    Date of Patent: December 10, 2013
    Assignee: Gambro UF Solutions, Inc.
    Inventors: Howard R. Levin, Mark Gelfand, John O'Mahony, Hans-Dietrich Polaschegg
  • Publication number: 20130261529
    Abstract: An extracorporeal blood processing method using a blood circuit comprising a pair of blood passages attached to opposite flow ends of a blood treatment device and said blood circuit is mounted on a blood pump console, the method includes: withdrawing blood from a vascular system of a human patient and drawing the blood into the blood circuit; pumping the withdrawn blood through one of the pair of blood passages using a first blood pump of the console and into the blood treatment device; pumping the treated blood from the treatment device through the other of the pair of blood passages using a second blood pump of the console; infusing the treated blood from the other blood passage and into the vascular system of the patient, and periodically reversing a flow direction of blood through the pair of blood passages and blood treatment device.
    Type: Application
    Filed: May 29, 2013
    Publication date: October 3, 2013
    Applicant: Gambro UF Solutions, Inc.
    Inventor: John O'Mahony
  • Patent number: 8475398
    Abstract: An extracorporeal blood processing method using a blood circuit comprising a pair of blood passages attached to opposite flow ends of a blood treatment device and said blood circuit is mounted on a blood pump console, the method includes: withdrawing blood from a vascular system of a human patient and drawing the blood into the blood circuit; pumping the withdrawn blood through one of the pair of blood passages using a first blood pump of the console and into the blood treatment device; pumping the treated blood from the treatment device through the other of the pair of blood passages using a second blood pump of the console; infusing the treated blood from the other blood passage and into the vascular system of the patient, and periodically reversing a flow direction of blood through the pair of blood passages and blood treatment device.
    Type: Grant
    Filed: November 6, 2009
    Date of Patent: July 2, 2013
    Assignee: Gambro uf Solutions, Inc.
    Inventor: John O'Mahony
  • Publication number: 20120323157
    Abstract: A method and apparatus for controlling blood withdrawal and infusion flow rate with the use of a pressure controller. The pressure controller uses pressure targets based upon occlusion limits that are calculated as a function of flow. The controller has the ability to switch from controlling withdrawal pressure to controlling infusion pressure based upon the detection of an occlusion. The controller distinguishes between partial and total occlusions of the withdrawal vein providing blood access. Depending on the nature of occlusion, the controller limits or temporarily reverses blood flow and, thus, prevents withdrawal vessel collapse or reverses blood flow to quickly infuse blood into the vessel without participation from operator.
    Type: Application
    Filed: August 24, 2012
    Publication date: December 20, 2012
    Applicant: GAMBRO UF Solutions, Inc.
    Inventors: John O'MAHONY, Mark GELFAND, Edward G. RYCHLICK